Link to Pubmed [PMID] – 32526181
Link to DOI – S1931-3128(20)30300-010.1016/j.chom.2020.05.018
Cell Host Microbe 2020 Jun; 27(6): 856-858
Human monoclonal antibodies are immune weapons that hold great promise for treating Marburg virus (MARV) infection. In this issue, Ilinykh et al. unveil non-neutralizing inhibitory properties of antibodies to the Wing region of the viral spike, which alongside with neutralizers are pivotal to in vivo protection against MARV infection.